Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pericyte | 18 studies | 33% ± 13% | |
| fibroblast | 10 studies | 26% ± 8% | |
| type I pneumocyte | 7 studies | 21% ± 4% | |
| smooth muscle cell | 6 studies | 22% ± 5% | |
| adipocyte | 6 studies | 23% ± 5% | |
| type II pneumocyte | 5 studies | 21% ± 1% | |
| club cell | 5 studies | 21% ± 5% | |
| mesothelial cell | 4 studies | 36% ± 8% | |
| connective tissue cell | 4 studies | 21% ± 3% | |
| epithelial cell | 4 studies | 25% ± 5% | |
| luminal hormone-sensing cell of mammary gland | 4 studies | 28% ± 7% | |
| myofibroblast cell | 3 studies | 22% ± 2% | |
| endothelial cell | 3 studies | 22% ± 4% | |
| cholangiocyte | 3 studies | 52% ± 20% | |
| hepatocyte | 3 studies | 66% ± 31% | |
| luminal cell of prostate epithelium | 3 studies | 24% ± 5% | |
| secretory cell | 3 studies | 27% ± 9% | |
| GABAergic neuron | 3 studies | 37% ± 6% | |
| glutamatergic neuron | 3 studies | 31% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 1396.39 | 966 / 966 | 99% | 31.73 | 520 / 527 |
| pancreas | 100% | 639.20 | 327 / 328 | 98% | 25.32 | 175 / 178 |
| breast | 100% | 939.51 | 459 / 459 | 96% | 60.32 | 1074 / 1118 |
| lung | 100% | 2147.00 | 578 / 578 | 94% | 21.76 | 1085 / 1155 |
| stomach | 97% | 906.42 | 348 / 359 | 96% | 29.29 | 274 / 286 |
| liver | 99% | 1199.83 | 224 / 226 | 91% | 31.03 | 370 / 406 |
| adrenal gland | 98% | 769.57 | 252 / 258 | 87% | 27.39 | 201 / 230 |
| bladder | 100% | 988.86 | 21 / 21 | 80% | 17.93 | 403 / 504 |
| esophagus | 91% | 760.38 | 1314 / 1445 | 89% | 17.22 | 162 / 183 |
| uterus | 96% | 542.28 | 164 / 170 | 77% | 17.69 | 353 / 459 |
| prostate | 97% | 614.83 | 238 / 245 | 75% | 9.03 | 376 / 502 |
| kidney | 78% | 344.85 | 69 / 89 | 84% | 18.14 | 755 / 901 |
| thymus | 82% | 277.10 | 536 / 653 | 65% | 12.65 | 396 / 605 |
| skin | 100% | 1079.28 | 1806 / 1809 | 42% | 4.17 | 199 / 472 |
| ovary | 72% | 276.39 | 129 / 180 | 63% | 7.41 | 270 / 430 |
| brain | 62% | 420.64 | 1643 / 2642 | 48% | 4.12 | 338 / 705 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.16 | 1 / 1 |
| blood vessel | 100% | 1621.98 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1122.23 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 845.93 | 240 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 12.13 | 36 / 45 |
| heart | 51% | 168.30 | 437 / 861 | 0% | 0 | 0 / 0 |
| muscle | 16% | 42.45 | 131 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 0.62 | 3 / 29 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.08 | 1 / 80 |
| peripheral blood | 0% | 1.67 | 4 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
| GO_0009966 | Biological process | regulation of signal transduction |
| GO_0005515 | Molecular function | protein binding |
| Gene name | LURAP1L |
| Protein name | Leucine rich adaptor protein 1-like |
| Synonyms | C9orf150 HYST0841 |
| Description | |
| Accessions | ENST00000319264.4 Q8IV03 |